VANCOUVER, March 17 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:
ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company,
is scheduled to participate in the Lehman Brothers Eleventh Annual Global
Healthcare Conference, which is being held March 18-20 in Miami Beach,
Dr. William Hunter, Angiotech's President and Chief Executive Officer, is
scheduled to present on Thursday, March 20, beginning at approximately 10:45
am ET. A question and answer session will immediately follow the presentation.
A live webcast of Dr. Hunter's remarks and the question and answer
session will be available to all interested parties on the company's website,
www.angiotech.com, under the Investors section.
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical interventions
and acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP),
please visit our website at www.angiotech.com.
For further information:
For further information: Deirdre Neary, Manager, Investor Relations,
Angiotech Pharmaceuticals, Inc., (604) 222-7056, firstname.lastname@example.org